Editas Medicine, Inc.EDITNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-6.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-30.68%
20243.35%
2023-1.49%
2022-7.19%
202112.74%
20204.68%
201917.35%
20188.93%
20179.17%
2016155.66%